Andreas Weiler
Lonza AG Muenchensteinerstrasse
Biography
Andreas Weiler is the Global Business Unit Head of Emerging Technologies at Lonza where he oversees the Cell and Gene Therapy Contract Manufacturing businesses. Before joining Lonza he worked for Sigma Aldrich (SAFC), another leading CDMO (Contract Development and Manufacturing Organization) to the Pharma/biotech industries, for over 17 years where he held several positions as Business Director and finally as the Head of Strategic Marketing to the organization. Since 2015, when Andreas joined Lonza, Cell and Gene Therapy sales have more than doubled and the manufacturing footprint expanded significantly to cover the globe with facilities in North America, Europe and Asia. Andreas holds a PhD in Organic Chemistry from University of Freiburg and an MBA degree.
Abstract
Abstract : Medicines of Tomorrow